Fiasp Flextouch 100 IU Pen 3 ML

Abbott India Ltd.

Pack of 3 ML

MRP ₹914.76

₹777.55

₹304.92/ML

15% off applied
*MRP inclusive of all taxes
Get it By
Change
Choose your location

Use your current location

Login to view saved addresses

100% genuine medicines

Safe & secure payments

15 days Easy returns

Prescription required for this medicine

Store in refrigerator or (2o - 8o C) Do Not Freeze

compositionComposition
Regular Aspart (100 Iu)

About Fiasp Flextouch 100 IU Pen 3 ML

Fiasp Flextouch is an injectable medical device used to manage diabetes mellitus in both adults and children over the age of 1. Diabetes mellitus is a chronic condition where the body has high blood sugar levels due to insufficient insulin production or reduced sensitivity of body cells to insulin.

This device contains insulin which helps lower blood sugar levels quickly, usually within 10-20 minutes after administration and lasts for about 3-4 hours.

Fiasp Flextouch is suitable for use in adults and children who are at least 1 year old. However, it's important to consult your doctor before starting treatment, especially if you have liver, kidney, or heart problems, hormonal issues, or if you have recently made significant changes to your diet or exercise routine.

Last Updated On 24 Aug. 2023 | 7:44AM (IST)

Certified Content

Written by

Dr. Lakshmi Vaswani
Dr. Lakshmi Vaswani

Medical Content Consultant | 16 years

MBBS, Dip.Pathology, MBA (Healthcare Services)

Reviewed by

Dr. Snigdha Sharma
Dr. Snigdha Sharma

Clinical Health & Medical Reviewer | 6 years

MBBS

Check out Editorial Policy

References

  • Insulin Aspart . (2007, May 1). https://www.fda.gov/media/71387/download
  • Rubin, R., Khanna, N. R., & McIver, L. A. (2022). Aspart Insulin. StatPearls. National Library of Medicine. https://www.ncbi.nlm.nih.gov/books/NBK500030/
  • Insulin Aspart (rDNA Origin) Injection: MedlinePlus Drug Information. (n.d.). https://medlineplus.gov/druginfo/meds/a605013.html
  • Pearson, T. L. (2010). Practical aspects of insulin pen devices. Journal of diabetes science and technology, 4(3), 522-531.
  • Graff, M. R., & McClanahan, M. A. (1998). Assessment by patients with diabetes mellitus of two insulin pen delivery systems versus a vial and syringe. Clinical therapeutics, 20(3), 486-496.
  • Adolfsson, P., Hartvig, N. V., Kaas, A., Møller, J. B., & Hellman, J. (2020). Increased time in range and fewer missed bolus injections after introduction of a smart connected insulin pen. Diabetes technology & therapeutics, 22(10), 709-718.
Was this product description useful?
100 people find this information helpful

Disclaimer

We, at Truemeds make a diligent attempt to deliver accurate, expert- drafted and thoroughly reviewed medicine related information to our consumers. However, it should, by no means, be considered a substitute for prescription from a certified doctor or a trustworthy doctor-patient relationship. In fact we detest any form of self medication without expert advice. The sole purpose of the information on our portal is to educate our consumers, which helps improve the communication between a doctor and a patient. The information by no means is complete in its entirety and should not be used to diagnose or treat any medical condition. No amount of information can replace the experience and expertise of a doctor, therefore his/her advice always holds priority and should be followed appropriately.

Subscribe

Claim your complimentary health and fitness tips subscription and stay updated on our newest promotions.

Download Truemeds

Manage your health with ease Download Truemeds today!Get easy access to medicine refills, health information, and more. With our app, you'll never have to wait in line again. Download now and start taking control of your health.

playstoreIcon

Contact Us

Our customer representative team is available 7 days a week from 9 am - 9 pm.


v3.4.2

copyright2024 - Truemeds | All rights reserved

Our Payment Partners

paymentPartnerpaymentPartnerpaymentPartnerpaymentPartnerpaymentPartner
paymentPartnerpaymentPartnerpaymentPartnerpaymentPartner